NCT06669611
- Conditions
- Nasopharyngeal Cancinoma (NPC)
- Locations
-
- SunYat-senU Guangzhou, Guangdong, China
Clinical trial condition
Nasopharyngeal Cancinoma (NPC)
Explore clinical trials studying Nasopharyngeal Cancinoma (NPC). Study availability and eligibility vary by location and protocol.
40 public trials
21 recruiting studies
Nasopharyngeal Cancinoma (NPC) trial results
Not Yet Recruiting
Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma
NCT07692906
- Conditions
- Nasopharyngeal Cancinoma (NPC)
- Locations
-
Not specified
Not Yet Recruiting
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT07524413
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC), +9 more
- Locations
-
Not specified
Not Yet Recruiting
MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial
NCT07381699
- Conditions
- Nasopharyngeal Cancinoma (NPC)
- Locations
-
Not specified
Not Yet Recruiting
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
NCT07385079
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC), +9 more
- Locations
-
Not specified
Not Yet Recruiting
Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT07373990
- Conditions
- Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Cancinoma (NPC), +9 more
- Locations
-
Not specified
Not Yet Recruiting
Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
NCT07238569
- Conditions
- Nasopharangeal Cancer, Nasopharyngeal Cancinoma (NPC)
- Locations
-
Not specified
Not Yet Recruiting
Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma
NCT07129772
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancer Recurrent, +13 more
- Locations
-
- Department of Clinical Oncology, Queen Mary Hospital Hong Kong
Not Yet Recruiting
EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07138989
- Conditions
- Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
- Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China
Not Yet Recruiting
Radiotherapy Omitting Prophylactic Neck Irradiation With Neoadjuvant and Adjuvant Toripalimab in Nasopharyngeal Carcinoma
NCT07110558
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Cancinoma (NPC), +12 more
- Locations
-
- Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China